JOHN HOPE FRANKLIN CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1838-01-01

Employees: 5K

Market Cap: -

Website: http://www.duke.edu

Clinical Trials

ENLIGHTEN: Exercise and NutritionaL Interventions for coGnitive and Cardiovascular HealTh ENhancement

Not Applicable

Completed

Conditions: Cognitive Impairment, no Dementia (CIND)

Interventions: Behavioral: Aerobic Exercise
Other: Health education control
Behavioral: DASH diet

First Posted Date: 2012-04-09

Last Posted Date: 2018-04-18

Lead Sponsor: Duke University

Target Recruit Count: 160

Registration Number: NCT01573546

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Tailored Smoking Cessation Treatment for LIVE FOR LIFE® Participants

Phase 2

Terminated

Conditions: Cigarette Smoking
Nicotine Dependence

Interventions: Drug: bupropion (Zyban)
Drug: varenicline (Chantix)
Drug: nicotine patches

First Posted Date: 2012-03-22

Last Posted Date: 2014-12-24

Lead Sponsor: Duke University

Target Recruit Count: 19

Registration Number: NCT01560507

Locations: 🇺🇸
Duke Center forSmoking Cessation, Durham, North Carolina, United States
🇺🇸
Duke Center for Smoking Cessation, Raleigh, North Carolina, United States

Once-Daily Asenapine for Schizophrenia

Phase 4

Completed

Conditions: Schizophrenia

Interventions: Drug: Asenapine 5 mg twice daily
Drug: Asenapine 10 mg daily in the evening

First Posted Date: 2012-03-08

Last Posted Date: 2014-05-26

Lead Sponsor: Duke University

Target Recruit Count: 30

Registration Number: NCT01549041

Locations: 🇺🇸
Central Regional Hospital, Butner, North Carolina, United States

Standard Percutaneous Nephrolithotomy Percutaneous Nephrolithotomy (PNL) Versus Tubeless PNL Versus Tubeless Stentless PNL

Phase 3

Completed

Conditions: Nephrolithotomy

Interventions: Procedure: Standard Percutaneous nephrolithotomy

First Posted Date: 2012-03-08

Last Posted Date: 2015-03-17

Lead Sponsor: Duke University

Target Recruit Count: 60

Registration Number: NCT01548196

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

The Effects of Antihistamines on Pre-Pulse Inhibition

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Placebo
Drug: Meclizine

First Posted Date: 2012-02-23

Last Posted Date: 2013-01-16

Lead Sponsor: Duke University

Target Recruit Count: 117

Registration Number: NCT01537471

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Exploring Massage Benefits for Arthritis of the Knee

Not Applicable

Completed

Conditions: Osteoarthritis

Interventions: Procedure: Massage Therapy

First Posted Date: 2012-02-23

Last Posted Date: 2017-04-20

Lead Sponsor: Duke University

Target Recruit Count: 222

Registration Number: NCT01537484

Locations: 🇺🇸
Yale-Griffin Prevention Research Center, Integrative Medicine Center at Griffin Hospital, Derby, Connecticut, United States
🇺🇸
Atlantic Health System -- Atlantic Health Integrative Medicine, Morristown, New Jersey, United States
🇺🇸
Duke University Medical Center- Duke Integrative Medicine, Durham, North Carolina, United States

Eating Disorders in Type 1 Diabetes: Mechanisms of Comorbidity

Completed

Conditions: Type 1 Diabetes
Eating Disorder

First Posted Date: 2012-01-20

Last Posted Date: 2014-08-26

Lead Sponsor: Duke University

Target Recruit Count: 83

Registration Number: NCT01513746

Locations: 🇺🇸
Duke University Health System, Durham, North Carolina, United States

Prospective Randomized Evaluation of a Two and Three Piece Total Ankle Replacement

Not Applicable

Completed

Conditions: Ankle Osteoarthritis

Interventions: Device: STAR Total Ankle Replacement
Device: Salto-Talaris Total Ankle Replacement

First Posted Date: 2012-01-05

Last Posted Date: 2021-05-05

Lead Sponsor: Duke University

Target Recruit Count: 100

Registration Number: NCT01504438

Locations: 🇺🇸
Duke Medical Plaza Page Road, Durham, North Carolina, United States

Zevalin and Velcade in Relapsed/Refractory Mantle Cell Lymphoma

Phase 2

Terminated

Conditions: Mantle-Cell Lymphoma

Interventions: Drug: Rituximab, Bortezomib,Y90 ibritumomab tiuxetan

First Posted Date: 2011-12-22

Last Posted Date: 2015-07-15

Lead Sponsor: Duke University

Target Recruit Count: 5

Registration Number: NCT01497275

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Weight Loss Among Adults in Beijing, China

Not Applicable

Completed

Conditions: Obesity
Hypertension

Interventions: Behavioral: Text Messaging and Behavior Counseling

First Posted Date: 2011-12-14

Last Posted Date: 2014-07-29

Lead Sponsor: Duke University

Target Recruit Count: 123

Registration Number: NCT01491906

Locations: 🇨🇳
Peking University, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy